Marci Peek, MT, LAT

Marci began her research career in 1999 as a study coordinator at the Pfizer Phase I unit in Ann Arbor, Mi, where she ran first-in-human, bioequivalent, food effect, proof-of-concept, and PK/PD studies. Her expertise includes project management, study scheduling, specimen collection and processing, institutional review board consulting, and protocol editing. She also has a wealth of drug safety experience, including adverse event reporting to the FDA and other worldwide regulatory agencies for clinical studies and post-marketed drugs. Marci received her RLAT certification in 2012.